Therefore, if the physician identifies a woman younger than 51 with SSBP and HTN, likely the treatment of choice would be a mineralocorticoid receptor antagonist or potentially an ALDO synthase inhibitor (25). The gene discussed is NR3C2; the disease is hypertensive disorder.